AirPhysio Natural Breathing Solution For COPD/Asthma Sufferers – Video Released

3 years ago

Life Wellness Healthcare has released a live demonstration of its AirPhysio device for those wishing to see how the device…

Chronic Bronchitis Symptom Relief – Shortness Of Breath AirPhysio Video Launched

3 years ago

Life Wellness Healthcare, the official US provider for the AirPhysio OPEP device, has launched a new educational video on its…

US Asthma Drug-Free Symptom Management – AirPhysio Mucus Reduction Device Launch

3 years ago

Life Wellness Healthcare has relaunched the AirPhysio OPEP device on its online store to help asthma sufferers across the country.…

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

3 years ago

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative…

ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021

3 years ago

ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021 Conference call and webcast on Tuesday,…

Wesana Provides Updates on Build-out of Third Clinic

3 years ago

Naperville clinic to open Spring 2022CHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc.  (“Wesana” or…

Roivant to Present at Targeted Protein Degradation Conference

3 years ago

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today…

 Inventiva announces filing of its 2021 Universal Registration Document and 2021 Annual Report on Form 20-F

3 years ago

Daix (France), Long Island City (New York, United States), March 11, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…

Sienna Senior Living Enters Into an Agreement to Purchase a Retirement Residence in Saskatchewan

3 years ago

MARKHAM, Ontario, March 11, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX:SIA) announced today that…

Cellectis to Participate in Two Upcoming Investor Conferences in March

3 years ago

NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology…